Historical Valuation
HUTCHMED (China) Ltd (HCM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.61 is considered Undervalued compared with the five-year average of 19.36. The fair price of HUTCHMED (China) Ltd (HCM) is between 40.99 to 66.62 according to relative valuation methord. Compared to the current price of 14.77 USD , HUTCHMED (China) Ltd is Undervalued By 63.96%.
Relative Value
Fair Zone
40.99-66.62
Current Price：14.77
63.96%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
HUTCHMED (China) Ltd (HCM) has a current Price-to-Book (P/B) ratio of 9.54. Compared to its 3-year average P/B ratio of 7.82 , the current P/B ratio is approximately 22.09% higher. Relative to its 5-year average P/B ratio of 6.63, the current P/B ratio is about 43.99% higher. HUTCHMED (China) Ltd (HCM) has a Forward Free Cash Flow (FCF) yield of approximately -2.10%. Compared to its 3-year average FCF yield of -1.25%, the current FCF yield is approximately 68.44% lower. Relative to its 5-year average FCF yield of -3.60% , the current FCF yield is about -41.52% lower.
P/B
Median3y
7.82
Median5y
6.63
FCF Yield
Median3y
-1.25
Median5y
-3.60
Competitors Valuation Multiple
AI Analysis for HCM
The average P/S ratio for HCM competitors is 37.91, providing a benchmark for relative valuation. HUTCHMED (China) Ltd Corp (HCM.O) exhibits a P/S ratio of 3.61, which is -90.49% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for HCM
1Y
3Y
5Y
Market capitalization of HCM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HCM in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is HCM currently overvalued or undervalued?
HUTCHMED (China) Ltd (HCM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.61 is considered Undervalued compared with the five-year average of 19.36. The fair price of HUTCHMED (China) Ltd (HCM) is between 40.99 to 66.62 according to relative valuation methord. Compared to the current price of 14.77 USD , HUTCHMED (China) Ltd is Undervalued By 63.96% .
What is HUTCHMED (China) Ltd (HCM) fair value?
HCM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of HUTCHMED (China) Ltd (HCM) is between 40.99 to 66.62 according to relative valuation methord.
How does HCM's valuation metrics compare to the industry average?
The average P/S ratio for HCM's competitors is 37.91, providing a benchmark for relative valuation. HUTCHMED (China) Ltd Corp (HCM) exhibits a P/S ratio of 3.61, which is -90.49% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for HUTCHMED (China) Ltd (HCM) as of Jan 09 2026?
As of Jan 09 2026, HUTCHMED (China) Ltd (HCM) has a P/B ratio of 9.54. This indicates that the market values HCM at 9.54 times its book value.
What is the current FCF Yield for HUTCHMED (China) Ltd (HCM) as of Jan 09 2026?
As of Jan 09 2026, HUTCHMED (China) Ltd (HCM) has a FCF Yield of -2.10%. This means that for every dollar of HUTCHMED (China) Ltd’s market capitalization, the company generates -2.10 cents in free cash flow.
What is the current Forward P/E ratio for HUTCHMED (China) Ltd (HCM) as of Jan 09 2026?
As of Jan 09 2026, HUTCHMED (China) Ltd (HCM) has a Forward P/E ratio of 14.28. This means the market is willing to pay $14.28 for every dollar of HUTCHMED (China) Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for HUTCHMED (China) Ltd (HCM) as of Jan 09 2026?
As of Jan 09 2026, HUTCHMED (China) Ltd (HCM) has a Forward P/S ratio of 3.61. This means the market is valuing HCM at $3.61 for every dollar of expected revenue over the next 12 months.